Akute Herzinsuffizienz
详细信息 查看全文
- 作者：U. Janssens (1) uwe.janssens@sah-eschweiler.de
- 关键词：Heart failure – Diagnosis – Vasodilators – Diuretics – Catecholamines
- 刊名：Medizinische Klinik
- 出版年：2012
- 出版时间：June 2012
- 年：2012
- 卷：107
- 期：5
- 页码：397-425
- 全文大小：1.4 MB
- 参考文献：1. Neumann T, Biermann J, Erbel R et al (2009) Herzinsuffizienz: H?ufigster Grund für Krankhenhausaufenthalte. Medizinische und ?konomische Aspekte. Dtsch Arztebl Int 106:269–275
2. Schappert SM, Rechtsteiner EA (2008) Ambulatory medical care utilization estimates for 2006. Natl Health Stat Report 8:1–29
3. Schappert SM, Rechtsteiner EA (2011) Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13:1–38
4. Weintraub NL, Collins SP, Pang PS et al (2010) Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation 122:1975–1996
5. Berry C, Murdoch DR, McMurray JJ (2001) Economics of chronic heart failure. Eur J Heart Fail 3:283–291
6. Janssens U (2009) Die akute Herzinsuffizienz: Diagnostik und Monitoring. Dtsch Med Wochenschr 134:1287–1292
7. Cowie MR, Mosterd A, Wood DA et al (1997) The epidemiology of heart failure. Eur Heart J 18:208–225
8. Mosterd A (1999) Heart failure in the population at large; news from the real world. Eur Heart J 20:398–399
9. Mosterd A, Hoes AW, Bruyne MC de et al (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; the Rotterdam Study. Eur Heart J 20:447–455
10. McMurray JJ, Stewart S (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83:596–602
11. Janssens U, Werdan K (2006) Erforderliches Monitoring auf der Intensivstation. Herz 31:749–760
12. Statistisches Bundesamt (2011) Statistisches Bundesamt, Wiesbaden, http://www.destatis.de. Zugegriffen: 25.03.2012
13. Blüthgen A (2002) Differenzialdiagnostik des kardialen Versagens. In: Eckart J, Forst H, Burchardi H (Hrsg) Intensivmedizin Kompendium und Repetitorium zur interdisziplin?ren Fort- und Weiterbildung. Ecomed, Landsberg, S 1–12
14. Buerke M, Lemm H, Russ M et al (2010) Diagnostik und Therapie bei akut dekompensierter Herzinsuffizienz und kardiogenem Schock. Internist (Berl) 51:963–974
15. Joseph SM, Cedars AM, Ewald GA et al (2009) Acute decompensated heart failure: contemporary medical management. Tex Heart Inst J 36:510–520
16. Acute Decompensated Heart Failure National Registry (ADHERE?) (2007) Core Module Q1 2006. Final Cumulative National Benchmark Report
17. Gheorghiade M, Abraham WT, Albert NM et al (2006) Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296:2217–2226
18. Perna ER, Barbagelata A, Grinfeld L et al (2006) Overview of acute decompensated heart failure in Argentina: lessons learned from 5 registries during the last decade. Am Heart J 151:84–91
19. Cleland JG, Swedberg K, Cohen-Solal A et al (2000) The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2:123–132
20. Nieminen MS, Brutsaert D, Dickstein K et al (2006) Euroheart failure survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725–2736
21. Zannad F, Mebazaa A, Juilliere Y et al (2006) Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 8:697–705
22. Tavazzi L, Maggioni AP, Lucci D et al (2006) Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 27:1207–1215
23. Metra M, Felker GM, Zaca V et al (2010) Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. Int J Cardiol 144:175–179
24. Greenberg B (2012) Acute decompensated heart failure – treatments and challenges. Circ J 76:532–543
25. Nieminen MS, Harjola VP (2005) Definition and epidemiology of acute heart failure syndromes. Am J Cardiol 96:5G–10G
26. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Eur Heart J 29:2388–2442
27. Nieminen MS, Bohm M, Cowie MR et al (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26:384–416
28. Drexler H, Bonin J von (2002) Kardiogener Schock nach Myokardinfarkt: Therapieans?tze. In: Eckart J, Forst H, Burchardi H (Hrsg) Intensivmedizin – Kompendium und Repetitorium zur interdisziplin?ren Fort- und Weiterbildung. Ecomed, Landsberg, S 1–12
29. B?hm M (2002) Pathophysiologie der Herzinsuffizienz heute. Herz 27:75–91
30. Cairns CB (1996) Heart failure and pulmonary edema. In: Tintinalli JE, Ruiz E, Krome RL (Hrsg) Emergency medicine. McGraw-Hill, New York, S 354–357
31. Wollert KC, Drexler H (1998) Akute Herzinsuffizienz. Internist (Berl) 39:459–466
32. Adams HA, Baumann G, G?nsslein A et al (2001) Die Definition der Schockformen. Intensivmedizin 38:541–553
33. Janssens U, Graf J (2004) Was ist ?Schock“. Internist (Berl) 45:258–266
34. Hochman JS (2003) Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107:2998–3002
35. Mitaka C, Hirata Y, Yokoyama K et al (2003) Relationships of circulating nitrite/nitrate levels to severity and multiple organ dysfunction syndrome in systemic inflammatory response syndrome. Shock 19:305–309
36. Kierdorf H (2009) Einsatz von Nierenersatzverfahren bei akut dekompensierter Herzinsuffizienz. Intensivmedizin 46:421–428
37. Adams KF Jr, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209–216
38. Ronco C, Haapio M, House AA et al (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539
39. Schiff GD, Fung S, Speroff T et al (2003) Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med 114:625–630
40. Cleland JG, Swedberg K, Follath F et al (2003) The Euro Heart Failure survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:442–463
41. Killip T, III, Kimball JT (1967) Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20:457–464
42. Tsai TH, Chua S, Hussein H et al (2011) Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention. Crit Care Med 39:436–442
43. Forrester JS, Diamond G, Chatterjee K et al (1976) Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N Engl J Med 295:1404–1413
44. Nohria A, Tsang SW, Fang JC et al (2003) Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41:1797–1804
45. Chung P, Hermann L (2006) Acute decompensated heart failure: formulating an evidence-based approach to diagnosis and treatment (part I). Mt Sinai J Med 73:506–515
46. Adams HA, Baumann G, Cascorbi I et al (2005) Empfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI. Teil 3: Kardialer Schock. Intensivmedizin 42:196–210
47. Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167
48. Remme WJ, Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22:1527–1560
49. Christenson RH (2008) What is the value of B-type natriuretic peptide testing for diagnosis, prognosis or monitoring of critically ill adult patients in intensive care? Clin Chem Lab Med 46:1524–1532
50. Kociol RD, Pang PS, Gheorghiade M et al (2010) Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 56:1071–1078
51. Janssens U (2001) Monitoring des herzkranken Intensivpatienten. Intensivmedizin 38:232–250
52. Janssens U (2000) H?modynamisches Monitoring. Internist (Berl) 41:995–1010
53. Müller T, Pfeifer M, Muders F (2003) Das Monitoring der zentralven?sen und gemischtven?sen Sauerstoffs?ttigung in der Intensivmedizin. Physiologische und technische Grundlagen, Indikationen und Aussagen. Intensivmedizin 40:711–719
54. Binanay C, Califf RM, Hasselblad V et al (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294:1625–1633
55. Goedje O, Hoeke K, Lichtwarck-Aschoff M et al (1999) Continuous cardiac output by femoral arterial thermodilution calibrated pulse contour analysis: comparison with pulmonary arterial thermodilution. Crit Care Med 27:2407–2412
56. Cotter G, Moshkovitz Y, Kaluski E et al (2003) The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 5:443–451
57. Janssens U, Graf J (2004) Systemische Optimierung des Sauerstoffangebotes. Kardiologische Optimierung. Anasthesiol Intensivmed Notfallmed Schmerzther 40:640–652
58. Müller E, Kindgen-Milles D (2002) Der Patient mit Lungenversagen und Myokardinsuffizienz. In: Eckart J, Forst H, Burchardi H (Hrsg) Intensivmedizin – Kompendium und Repetitorium zur interdisziplin?ren Fort- und Weiterbildung. Ecomed, Landsberg, S 1–10
59. Link A, B?hm M (2009) ESC Leitlinien 2008 – Leitlinien zur akuten Herzinsuffizienz. Intensivmedizin 46:377–382
60. Engelmann L (2009) Bedeutung und Einsatz der Beatmung bei akut dekompensierter Herzinsuffizienz. Intensivmedizin 46:391–398
61. Nava S, Carbone G, DiBattista N et al (2003) Noninvasive ventilation in cardiogenic pulmonary edema: a multicenter randomized trial. Am J Respir Crit Care Med 168:1432–1437
62. Mehta S, Jay GD, Woolard RH et al (1997) Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med 25:620–628
63. Park M, Lorenzi-Filho G, Feltrim MI et al (2001) Oxygen therapy, continuous positive airway pressure, or noninvasive bilevel positive pressure ventilation in the treatment of acute cardiogenic pulmonary edema. Arq Bras Cardiol 76:221–230
64. Sch?nhofer B, Kuhlen R, Neumann P et al (2008) Clinical practice guideline: non-invasive mechanical ventilation as treatment of acute respiratory failure. Dtsch Arztebl Int 105:424–433
65. Loo A van de (2002) Therapie h?modynamische wirksamer Herzrhythmusst?rungen. In: Eckart J, Forst H, Burchardi H (Hrsg) Intensivmedizin – Kompendium und Repetitorium zur interdisziplin?ren Fort- und Weiterbildung. Ecomed, Landsberg, S 1–15
66. Hamm CW, Bassand JP, Agewall S et al (2011) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32(23):2999–3054
67. Buccelletti F, Hermann L (2006) Acute decompensated heart failure: formulating an evidence-based approach to diagnosis and treatment (part II). Mt Sinai J Med 73:516–527
68. Vasan RS, Larson MG, Benjamin EJ et al (1999) Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33:1948–1955
69. Bayliss J, Norell M, Canepa-Anson R et al (1987) Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 57:17–22
70. Francis GS, Siegel RM, Goldsmith SR et al (1985) Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 103:1–6
71. De Bruyne LK (2003) Mechanisms and management of diuretic resistance in congestive heart failure. Postgrad Med J 79:268–271
72. Marx G, Cope T, McCrossan L et al (2004) Assessing fluid responsiveness by stroke volume variation in mechanically ventilated patients with severe sepsis. Eur J Anaesthesiol 21:132–138
73. Gunn SR, Pinsky MR (2001) Implications of arterial pressure variation in patients in the intensive care unit. Curr Opin Crit Care 7:212–217
74. Acute Decompensated Heart Failure National Registry (ADHERE?) (2004) The Adhere registry: second quarter 2003. National Benchmark Report
75. Emerman CL (2003) Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department. Rev Cardiovasc Med [Suppl 7] 4:13–20
76. Fonarow GC (2001) The treatment targets in acute decompensated heart failure. Rev Cardiovasc Med [Suppl 2] 2:7–12
77. Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797–805
78. M?llhoff T (2002) Einsatz vasoaktiver Substanzen bei Myokardinsuffizienz. In: Eckart J, Forst H, Burchardi H (Hrsg) Intensivmedizin – Kompendium und Repetitorium zur interdisziplin?ren Fort- und Weiterbildung. Ecomed, Landsberg, S 1–22
79. Cotter G, Metzkor E, Kaluski E et al (1998) Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351:389–393
80. Hirschl MM (2006) Aktuelles: Aortendissektion. Austrian J Hypertens 10:35–37
81. O’Connor CM, Starling RC, Hernandez AF et al (2011) Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365:32–43
82. McMurray JJ, Teerlink JR, Cotter G et al (2007) Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 298:2009–2019
83. Konstam MA, Gheorghiade M, Burnett JC Jr et al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297:1319–1331
84. Massie BM, O’Connor CM, Metra M et al (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363:1419–1428
85. Teerlink JR, Metra M, Felker GM et al (2009) Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373:1429–1439
86. Shah SJ, Blair JE, Filippatos GS et al (2009) Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am Heart J 157:1035–1041
87. Cleland JG, Teerlink JR, Senior R et al (2011) The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet 378:676–683
88. Lapp H, Mitrovic V, Franz N et al (2009) Cinaciguat (BAY 58–2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. Circulation 119:2781–2788
89. Delle-Karth G, Heinz G (2004) Levosimendan in Kardiologie und Intensivmedizin. Wien Klin Wochenschr 116:6–14
90. Communal C, Singh K, Sawyer DB et al (1999) Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100:2210–2212
91. Prondzinsky R, Werdan K (2004) Kardiogener Schock: Kriterien, gesicherte und ungesicherte Therapieverfahren. In: Eckart J, Forst H, Burchardi H (Hrsg) Intensivmedizin – Kompendium und Repetitorium zur interdisziplin?ren Fort- und Weiterbildung. Ecomed, Landsberg, S 1–22
92. Buerke M, Lemm H, Dietz S, Werdan K (2010) Infarktbedingter kardiogener Schock – Ursache, Diagnose und Behandlung. Intensivmedizin 47:597–611
93. Mebazaa A, Parissis J, Porcher R et al (2011) Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med 37:290–301
94. Ferrari M (2009) Die akute Herzinsuffizienz: Mechanische Kreislaufunterstützung. Dtsch Med Wochenschr 134:1474–1477 - 作者单位：1. Klinik für Innere Medizin, St. Antonius Hospital, Dechant-Deckers-Stra?e 8, 52249 Eschweiler, Deutschland
- 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Internal Medicine
Medicine/Public Health, general - 出版者：Urban & Vogel
- ISSN：1615-6722
文摘
Die Zahl der an Herzinsuffizienz Leidenden nahm in den letzten Jahren stetig zu. Sie wird als das führende kardiale Krankheitsbild des 21. Jahrhunderts angesehen. Ressourcen werden v. a. durch Krankenhauskosten in Anspruch genommen. Die koronare Herzkrankheit (KHK) allein oder in Kombination mit der arteriellen Hypertonie ist sicher die h?ufigste Ursache der Herzinsuffizienz. Bei nahezu 50% der Patienten mit akuter Herzinsuffizienz ist die linksventrikul?re Pumpfunktion erhalten. Die therapeutischen Ziele in der Behandlung der akuten Herzinsuffizienz sind rasche Stabilisierung der H?modynamik, Verbesserung der Symptome und des respiratorischen Status sowie der kurz- und langfristigen Prognose. Diuretika, Vasodilatatoren und positiv inotrope Substanzen stehen neben allgemeinen und supportiven Ma?nahmen im Zentrum der Versorgung. Klare und strukturierte Abl?ufe bei der Diagnostik und Therapie in der Notaufnahme, der Intensiv-, der Wach- und der Normalstation sind zwingend erforderlich.